Battling antibiotic-resistant pathogens one door knob at a time

New antimicrobial coating could revolutionize cleaning methods

We’ve gained a new weapon in the fight against harmful and often antibiotic-resistant pathogens with the development of a unique material engineered to limit disease spread and replace current cumbersome cleaning protocols on high-touch surfaces like door knobs and hand rails.

Using the Canadian Light Source (CLS) at the University of Saskatchewan (USask), researchers from the University of Windsor (UWindsor) have developed and tested a compound of ionic (salt-based) fluids and copper nanoparticles that can coat surfaces and provide germ-free protection that lasts far longer than conventional bleach-based cleaning. For Dr. Abhinandan (Ronnie) Banerjee, the composite material is far superior to “somebody with bleach and a rag trying to keep surfaces sanitized.”

Early in the Covid-19 pandemic, Banerjee and colleagues on the UWindsor’s Trant Team — a research group focused on synthetic bioorganic materials — set their sights on improving sanitizing protocols, which at the time often involved frequent application of compounds like bleach. “The problem with conventional sanitization techniques is it’s not a one-and-done kind of thing,” they said. “It requires a dedicated employee or automation” to keep surfaces germ free. Additionally, frequent wiping of a surface can etch the underlying material, creating even more opportunities for pathogens to gather.

Read more on the CLS website

Image: BioXAS Beamline

Credit: Canadian Light Source (CLS)

Undermining the foundations of bacterial resistance

Scientists from the University of Guelph have used the Canadian Light Source (CLS) at the University of Saskatchewan to better understand how several infectious bacteria, including E. coli., build a protective sugar-based barrier that helps cloak their cells.

Published in the Journal of Biological Chemistry, the Guelph research provides the very early steps toward new treatments for E. coli and a whole range of bacteria. Their particular focus is on strains of E. coli that cause urinary tract and bloodstream infections, particularly those that are antibiotic resistant.

The research is looking to understand the enzyme that many infectious bacteria use to build the foundations of their protective capsule. The capsule helps shield the bacterium from attack by the human immune system and exists in many clinically distinct variants.

Making vaccines or drugs that targets the capsule itself directly is impractical as such treatments would target only a few bacteria. Instead, the Guelph team is focused on a key enzyme that builds the capsule foundation. This foundation could serve as a common point of attack, allowing a single treatment for several key pathogens infecting humans and livestock.

“We are interested in the machinery that builds the bacterium’s protective layer,” said Dr. Chris Whitfield, Professor Emeritus in the Department of Molecular and Cellular Biology. “By understanding and targeting the machinery, we can render the pathogen unable to survive in the host”.

Read more on the Canadian Light Source website

Image : Matthew Kimber, Chris Whitfield, and enzyme